Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Sales of Property, Plant and Equipment (2012 - 2024)

Analysis

Precigen (PGEN) Sales of Property, Plant and Equipment (2012 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 57,000.00
Mar 31, 2024 3,000.00
Dec 31, 2023 37,000.00
Jun 30, 2023 61,000.00
Sep 30, 2022 156,000.00
Jun 30, 2022 291,000.00
Mar 31, 2022 147,000.00
Dec 31, 2021 469,000.00
Sep 30, 2021 279,000.00
Jun 30, 2021 314,000.00
Mar 31, 2021 1.94 Mn
Dec 31, 2020 4.65 Mn
Sep 30, 2020 305,000.00
Jun 30, 2020 842,000.00
Mar 31, 2020 684,000.00
Dec 31, 2019 327,000.00
Sep 30, 2019 185,000.00
Jun 30, 2019 109,000.00
Mar 31, 2019 67,000.00
Dec 31, 2018 337,000.00